Deferasirox Hexal

Deferasirox Hexal is an oral medication used to manage iron overload. It is commonly prescribed for conditions requiring iron chelation therapy. This product is manufactured by Hexal AG in the EU.

Deferasirox is primarily used for the treatment of chronic iron overload due to blood transfusions. It helps to remove excess iron from the body, which can be crucial for patients undergoing frequent blood transfusions. This medication is often referred to as an iron chelator and is used to manage conditions where iron accumulation poses a health risk.

Common effects of Deferasirox may include gastrointestinal issues such as nausea, vomiting, and diarrhea. Some users may also experience skin rashes or changes in liver function. It is important to monitor for any adverse reactions and consult a healthcare provider if concerns arise.

Deferasirox should be used with caution in patients with pre-existing liver or kidney conditions. Regular monitoring of liver and kidney function is recommended. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional.

Deferasirox may interact with certain medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.